Gerresheimer AG

Company Overview

Gerresheimer AG is the global partner in pharma primary packaging, drug delivery systems and solutions, with the wide product range for the pharma, health, biotech, and cosmetics industries. Gerresheimer operates approximately 40 manufacturing plants globally. Company’s broad product range includes pharmaceutical primary packaging and drug delivery systems and solutions for the safe and convenient administration of injected drugs: insulin pens, inhalers, on-body devices, prefillable syringes, vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems. As of November 2024, Gerresheimer Group comprises 43 subsidiaries and two associated companies consolidated across 16 countries. The company provides Gx Cap technology, which keeps track of prescription vials being opened and will send text reminders if doses go missed. This means pharmacists can monitor medication adherence and take prompt action, ensuring patients are actively adhering to their prescribed treatment regimen.

Financial Highlights (FY 2025)

Company's Business Segments

• Plastics and Devices : The Plastics and Devices division includes Complex, Customer-specific products for Simple, Safe Drug Delivery, System Solutions for Liquid Medicines, Solid Medicines, Services.
• Primary Packaging Glass : We offer a wide range of products and solutions for the Pharma Industries, Biotech Industries. Alongside Infusion, Dropper, Syrup Bottles, our product portfolio also includes High-quality specialty products such as Injection Vials, Ampoules, Cartridges made of Borosilicate Glass Tubing.
• Advanced Technologies : The Advanced Technologies Division develops Auto-injectors, Micro Pumps for the Subcutaneous delivery of Liquid Drugs, as well as Digital Platform Solutions for ensuring Drug Traceability, Improving Patient Treatment outcomes.